Cetuximab for esophageal cancer: An updated meta-analysis of randomized controlled trials

Increasing evidence indicates that cetuximab (CET) combined with chemoradiotherapy may be effective for patients with esophageal cancer. However, the recent results are still contradictory and no consensus has yet been reached on this issue.